Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPERIAL Study: OC-01 Nasal Spray for Dry Eye
NCT03688802Phase 2Completed
- Sponsor
- Oyster Point Pharma
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in dry eye disease (DED), sponsored by Oyster Point Pharma. Started Sep 2018; status: completed.
02
Drugs
varenicline
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03688802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688802.